West Pharmaceutical Services | WST - Operating Profit


West Pharmaceutical Services reported $162.5M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Align Technology USD 224.71M 40.06M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dentsply International USD 512M 401M Sep/2025
Haemonetics USD 67.4M 8.9M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
OraSure Technologies USD -6M 3.26M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
Repligen USD 12.68M 6.72M Sep/2025
Rockwell Medical USD 515K 1.84M Jun/2024
Solventum Corp USD 1.69B 1.47B Sep/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Terumo JPY 43.88B 1.21B Dec/2025
Utah Medical Products USD 3.76M 310K Sep/2024
West Pharmaceutical Services USD 162.5M 5.1M Dec/2025